Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v6-EN
Language English English
Date Updated 2017-07-01 2017-07-01
Drug Identification Number 02262339 02262339
Brand name NIASPAN NIASPAN
Common or Proper name Extended-release niacin Extended-release niacin
Company Name SUNOVION PHARMACEUTICALS CANADA INC SUNOVION PHARMACEUTICALS CANADA INC
Ingredients NICOTINIC ACID NICOTINIC ACID
Strength(s) 1000MG 1000MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C10AD C10AD
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-06-30 2017-06-30
Remaining supply date 2017-06-30 2017-06-30
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments Please note that NIASPAN FCT® 500 mg and 1000 mg will remain on the market Please note that NIASPAN FCT® 500 mg and 1000 mg will remain on the market
Health Canada comments